Dash Raju, Junaid Md, Mitra Sarmistha, Arifuzzaman Md, Hosen S M Zahid
Molecular Modeling and Drug Design Laboratory, Pharmacology Research Division, Bangladesh Council of Scientific and Industrial Research (BCSIR), Chittagong, 4220, Bangladesh.
Department of Anatomy, Dongguk University Graduate School of Medicine, Gyeongju, 38066, Republic of Korea.
J Mol Model. 2019 Mar 23;25(4):98. doi: 10.1007/s00894-019-3979-6.
Vascular endothelial growth factor receptor-2 (VEGFR-2) is one of the regulatory elements of angiogenesis that is expressed highly in various diseases and is also essential for solid tumor growth. The present study was aimed at identifying potent inhibitors of VEGFR-2 by considering herbal secondary metabolites; as natural molecules are less toxic than synthetic derivatives. A structure-based virtual screening protocol consisting of molecular docking, MM-GBSA and ADME/T analysis was initially used to screen a library of in vivo metabolites of the herbal ingredient. Using a fixed cutoff value, four potent virtual hits were identified from molecular docking, ADME/T and binding affinity calculations, which were considered further for molecular dynamics (MD) simulation to broadly describe the binding mechanisms to VEGFR-2. The results suggested that these molecules have high affinity for the catalytic region of VEGFR-2, and form strong hydrophobic and polar interactions with the amino acids involved in the binding site of ATP and linker regions of the catalytic site. Subsequently, the stability of the docked complexes and binding mechanisms were evaluated by MD simulations, and the energy of binding was calculated through MM-PBSA analysis. The results uncovered two virtual hits, designated ZINC14762520 and ZINC36470466, as VEGFR-2 inhibitors, and suggested that they bind to kinase domain in an ATP-competitive manner. These virtual hits will offer a suitable starting point for the further design of their various analogs, allowing a rational search for more effective inhibitors in the future. Graphical abstract.
血管内皮生长因子受体-2(VEGFR-2)是血管生成的调控元件之一,在多种疾病中高表达,对实体瘤生长也至关重要。本研究旨在通过考虑草药次生代谢产物来鉴定VEGFR-2的有效抑制剂;因为天然分子的毒性低于合成衍生物。最初使用由分子对接、MM-GBSA和ADME/T分析组成的基于结构的虚拟筛选方案来筛选草药成分的体内代谢产物库。使用固定的截止值,从分子对接、ADME/T和结合亲和力计算中鉴定出四个有效的虚拟命中物,进一步对其进行分子动力学(MD)模拟,以广泛描述与VEGFR-2的结合机制。结果表明,这些分子对VEGFR-2的催化区域具有高亲和力,并与参与ATP结合位点和催化位点连接区域的氨基酸形成强烈的疏水和极性相互作用。随后,通过MD模拟评估对接复合物的稳定性和结合机制,并通过MM-PBSA分析计算结合能。结果发现两个虚拟命中物,命名为ZINC14762520和ZINC36470466,作为VEGFR-2抑制剂,并表明它们以ATP竞争性方式结合到激酶结构域。这些虚拟命中物将为进一步设计其各种类似物提供合适的起点,以便未来合理寻找更有效的抑制剂。图形摘要。